The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
09
2018
accepted:
25
01
2019
entrez:
15
2
2019
pubmed:
15
2
2019
medline:
8
11
2019
Statut:
epublish
Résumé
Countries deliver vaccines either through routine health services or supplementary immunization activities (SIAs), usually community-based or door-to-door immunization campaigns. While SIAs have been successful at increasing coverage of vaccines in low- and middle-income countries, they may disrupt the delivery of routine health services. We examine the impact of SIAs on routine vaccine coverage in five low-income countries. Data on the number and timing of SIAs conducted in various countries was compiled by WHO and obtained through UNICEF. Information on the coverage of vaccines not targeted by SIAs (e.g., DPT) was extracted from the Demographic and Health Surveys. We focus on SIAs that took place between 1996 and 2013 in Bangladesh, Senegal, Togo, Gambia, and Cote d'Ivoire, and examine outcomes for children aged 12-59 months. To avoid biases resulting from non-random placement and timing of SIAs, we use age of a child at her first SIA as an instrumental variable for total exposure to SIAs. We find that SIA exposure reduced the likelihood of receiving routine vaccines in all the countries included in the study; the coefficients of interest are however statistically insignificant for Gambia and Cote d'Ivoire. In countries that witnessed statistically significant SIA-induced declines in the likelihood of obtaining DPT 3, measles as well as BCG, reductions ranged from 1.3 percentage points (Senegal) to 5.5 percentage points (Bangladesh). SIA exposure reduced routine vaccination rates in study countries. Efforts should be made to limit the detrimental impact of SIAs on the services provided by routine health systems.
Sections du résumé
BACKGROUND
Countries deliver vaccines either through routine health services or supplementary immunization activities (SIAs), usually community-based or door-to-door immunization campaigns. While SIAs have been successful at increasing coverage of vaccines in low- and middle-income countries, they may disrupt the delivery of routine health services. We examine the impact of SIAs on routine vaccine coverage in five low-income countries.
METHODS
Data on the number and timing of SIAs conducted in various countries was compiled by WHO and obtained through UNICEF. Information on the coverage of vaccines not targeted by SIAs (e.g., DPT) was extracted from the Demographic and Health Surveys. We focus on SIAs that took place between 1996 and 2013 in Bangladesh, Senegal, Togo, Gambia, and Cote d'Ivoire, and examine outcomes for children aged 12-59 months. To avoid biases resulting from non-random placement and timing of SIAs, we use age of a child at her first SIA as an instrumental variable for total exposure to SIAs.
RESULTS
We find that SIA exposure reduced the likelihood of receiving routine vaccines in all the countries included in the study; the coefficients of interest are however statistically insignificant for Gambia and Cote d'Ivoire. In countries that witnessed statistically significant SIA-induced declines in the likelihood of obtaining DPT 3, measles as well as BCG, reductions ranged from 1.3 percentage points (Senegal) to 5.5 percentage points (Bangladesh).
CONCLUSION
SIA exposure reduced routine vaccination rates in study countries. Efforts should be made to limit the detrimental impact of SIAs on the services provided by routine health systems.
Identifiants
pubmed: 30763389
doi: 10.1371/journal.pone.0212049
pii: PONE-D-18-26352
pmc: PMC6375584
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0212049Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Bull World Health Organ. 2007 Jun;85(6):449-57
pubmed: 17639242
J Epidemiol Community Health. 2013 Nov 1;67(11):947-52
pubmed: 23975755
Vaccine. 2016 Jul 19;34(33):3817-22
pubmed: 27269060
Soc Sci Med. 2005 Sep;61(5):989-1000
pubmed: 15955401
Curr Top Microbiol Immunol. 2006;304:195-220
pubmed: 16989271
Vaccine. 2001 Aug 14;19(31):4378-84
pubmed: 11483262
Science. 2005 Oct 28;310(5748):625-6
pubmed: 16254173
J Infect Dis. 2014 Nov 1;210 Suppl 1:S531-9
pubmed: 25316877
Int J Health Serv. 1997;27(4):767-90
pubmed: 9399118
J Infect Dis. 1997 Feb;175 Suppl 1:S183-8
pubmed: 9203714
Bull World Health Organ. 2012 Nov 1;90(11):822-30
pubmed: 23226894
Bull World Health Organ. 2009 Jul;87(7):535-41
pubmed: 19649368
Health Policy Plan. 2016 Nov;31(9):1225-31
pubmed: 27175031
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S4
pubmed: 19828062
J Infect Dis. 2014 Nov 1;210 Suppl 1:S504-13
pubmed: 24690667
Health Policy. 2004 Dec;70(3):327-45
pubmed: 15488998
S Afr Med J. 2001 Mar;91(3):249-54
pubmed: 11291425
Vaccine. 2007 Feb 26;25(10):1756-63
pubmed: 17229498
Vaccine. 2009 Jan 1;27(1):169-75
pubmed: 18789997
Health Policy. 2007 Sep;83(1):27-36
pubmed: 17174435
Soc Sci Med. 2003 Nov;57(10):1807-19
pubmed: 14499507
J Health Popul Nutr. 2003 Sep;21(3):193-204
pubmed: 14717565
Bull World Health Organ. 2016 Nov 1;94(11):794-805B
pubmed: 27821882
Expert Rev Vaccines. 2017 Feb;16(2):161-174
pubmed: 27690704
Am J Public Health. 2002 Jan;92(1):19-23
pubmed: 11772750
Vaccine. 2012 Jan 17;30(4):730-6
pubmed: 22137878
Vaccine. 2007 Jan 8;25(4):664-71
pubmed: 17049682
Health Policy Plan. 2017 Jul 1;32(6):800-808
pubmed: 28335014
Expert Rev Vaccines. 2010 May;9(5):447-9
pubmed: 20450316